DataCloudKnowledgetrainingcoordination

L1000 LINCS DCIC FIBR005 MCLF033SZ 6H O24 purmorphamine 4uM.tsv.gz (File)

Taxon:

Homo sapiens

Taxon (Entity type)

Subject:

MCLF033SZ

Subject (Entity type)

Project:

LINCS-2021

Project (Entity type)

File Format:

TSV

File Format (Entity type)

Dcc Asset:

datapackage.zip

Processed File (Entity type)

Dcc:

LINCS

DCC (Entity type)

Data Type:

gene expression profile

Data Type (Entity type)

Compression Format:

GZIP format

File Format (Entity type)

Biosample:

L1000 LINCS DCIC 2021 FIBR005 MCLF033SZ 6H O24 purmorphamine 4uM

Biosample (Entity type)

Assay Type:

landmark transcript profiling assay

Assay Type (Entity type)

Uncompressed Size In Bytes:191 KB

Size In Bytes:89.9 KB

Sha256:a1d8fd852a8795712403696b09fec59ace5562da0e976b4c98a5ec5ab11d1138

Persistent Id:drs://drs.lincs-dcic.org/5fe13bf3d92e157cc5d57bb971e8bd0a

Mime Type:application/gzip

Md5:5fe13bf3d92e157cc5d57bb971e8bd0a

Filename:L1000_LINCS_DCIC_FIBR005_MCLF033SZ_6H_O24_purmorphamine_4uM.tsv.gz

Creation Time:2021-01-21T00:00:00

Access Url:

drs://drs.lincs-dcic.org/5fe13bf3d92e157cc5d57bb971e8bd0a

Results found

Linked to

	Label	Description
	L1000 LINCS DCIC 2021 FIBR005 MCLF033SZ 6H O24 purmorphamine 4uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 FIBR005 MCLF033SZ 6H O24 purmorphamine 4uM

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.